Peter Dominiak Selected Research

Peter Dominiak Research Topics

Disease

8	Hypertension (High Blood Pressure) 01/2010 - 01/2003
5	Infarction (Infarctions) 04/2008 - 09/2002
4	Ischemia 11/2006 - 09/2002
3	Myocardial Infarction 11/2006 - 09/2002
2	Obesity 01/2010 - 09/2007
2	Insulin Resistance 01/2010 - 09/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2006 - 07/2003
2	Stroke (Strokes) 06/2005 - 07/2003
2	Ganglion Cysts (Ganglion) 04/2005 - 08/2002
2	Hypoxia (Hypoxemia) 01/2005 - 08/2003
2	Reperfusion Injury 09/2004 - 09/2002
1	Endotoxemia 01/2016
1	Cough 07/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2007
1	Body Weight (Weight, Body) 11/2006
1	Coronary Occlusion 11/2006
1	Proteinuria 03/2006
1	Diabetes Mellitus 03/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2004
1	Necrosis 09/2004
1	Myocardial Reperfusion Injury 09/2004
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2004
1	Diabetes Complications 04/2003
1	Hypersensitivity (Allergy) 03/2003
1	Hypertrophy 12/2002

Drug/Important Bio-Agent (IBA)

5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2008 - 12/2002
4	Messenger RNA (mRNA)IBA 08/2005 - 04/2003
3	LeptinIBA 01/2010 - 11/2006
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2006 - 09/2002
3	Proteins (Proteins, Gene)FDA Link 03/2006 - 08/2003
2	Ramipril (Altace)FDA LinkGeneric 07/2008 - 03/2006
2	Glucose (Dextrose)FDA LinkGeneric 09/2007 - 11/2006
2	Angiotensin IIIBA 10/2005 - 09/2002
2	Nitric Oxide Synthase (NO Synthase)IBA 08/2005 - 09/2003
2	Hexamethonium (Hexamethonium Bromide)IBA 04/2005 - 08/2002
2	Phosphotransferases (Kinase)IBA 09/2004 - 09/2002
2	AngiotensinsIBA 07/2003 - 04/2003
2	Endothelin-1 (Endothelin 1)IBA 12/2002 - 09/2002
1	KininsIBA 01/2016
1	triphenyltetrazoliumIBA 04/2008
1	Desipramine (Pertofrane)FDA LinkGeneric 11/2006
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 11/2006
1	Insulin (Novolin)FDA Link 11/2006
1	Antihypertensive Agents (Antihypertensives)IBA 03/2006
1	AlbuminsIBA 03/2006
1	Protein Isoforms (Isoforms)IBA 08/2005
1	eprosartan (Teveten)FDA Link 06/2005
1	CalciumIBA 06/2005
1	NitrendipineIBA 06/2005
1	Angiotensin II Type 1 Receptor BlockersIBA 06/2005
1	chelerythrineIBA 04/2005
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 04/2005
1	calcitonin gene-related peptide (8-37)IBA 04/2005
1	Transcription Factors (Transcription Factor)IBA 01/2005
1	IronIBA 01/2005
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2005
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2005
1	rho-Associated KinasesIBA 10/2004
1	fasudil (AT 877)IBA 10/2004
1	WortmanninIBA 09/2004
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2004
1	Simvastatin (Zocor)FDA LinkGeneric 09/2004
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 09/2004
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2003
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 08/2003
1	Erythropoietin FDA Link 08/2003
1	candesartan cilexetil (Amias)FDA Link 07/2003
1	ReninIBA 04/2003
1	2,5-dichloro-4-bromophenol (B 2)IBA 03/2003
1	BradykininIBA 03/2003
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2002
1	IsoenzymesIBA 09/2002
1	Trinitrotoluene (TNT)IBA 09/2002
1	Troponin T (Troponin T1)IBA 09/2002
1	Vasopressins (Vasopressin)IBA 09/2002
1	Vasoconstrictor AgentsIBA 09/2002
1	icatibantIBA 08/2002

Therapy/Procedure

2	Therapeutics 07/2003 - 01/2003
1	Secondary Prevention 06/2005
1	Percutaneous Coronary Intervention 09/2002